Role of Glycosylation/Deglycolysation Processes in Francisella tularensis Pathogenesis by Monique Barel & Alain Charbit
REVIEW
published: 21 March 2017
doi: 10.3389/fcimb.2017.00071
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 March 2017 | Volume 7 | Article 71
Edited by:
Marina Santic’,
University of Rijeka, Croatia
Reviewed by:
Jiri Stulik,
University of Defence, Czechia
Paul Edward Carlson,




Received: 13 January 2017
Accepted: 27 February 2017
Published: 21 March 2017
Citation:
Barel M and Charbit A (2017) Role of
Glycosylation/Deglycolysation
Processes in Francisella tularensis
Pathogenesis.




Processes in Francisella tularensis
Pathogenesis
Monique Barel 1, 2, 3* and Alain Charbit 1, 2, 3
1 Sorbonne Paris Cité, Bâtiment Leriche, Université Paris Descartes, Paris, France, 2 Institut National de la Santé et de la
Recherche Médicale, Institut Necker-Enfants Malades, INSERM U1151 -Team 11, Pathogenesis of Systemic Infections,
Paris, France, 3Centre National de la Recherche Scientifique, UMR8253, Paris, France
Francisella tularensis is able to invade, survive and replicate inside a variety of cell types.
However, in vivo F. tularensis preferentially enters host macrophages where it rapidly
escapes to the cytosol to avoid phagosomal stresses and to multiply to high numbers.
We previously showed that human monocyte infection by F. tularensis LVS triggered
deglycosylation of the glutamine transporter SLC1A5. However, this deglycosylation,
specifically induced by Francisella infection, was not restricted to SLC1A5, suggesting
that host protein deglycosylation processes in general might contribute to intracellular
bacterial adaptation. Indeed, we later found that Francisella infection modulated
the transcription of numerous glycosidase and glycosyltransferase genes in human
macrophages and analysis of cell extracts revealed an important increase of N and
O-protein glycosylation. In eukaryotic cells, glycosylation has significant effects on
protein folding, conformation, distribution, stability, and activity and dysfunction of protein
glycosylation may lead to development of diseases like cancer and pathogenesis of
infectious diseases. Pathogenic bacteria have also evolved dedicated glycosylation
machineries and have notably been shown to use these glycoconjugates as ligands
to specifically interact with the host. In this review, we will focus on Francisella and
summarize our current understanding of the importance of these post-translational
modifications on its intracellular niche adaptation.
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INTRODUCTION
Protein glycosylation is one of the most common post-translational modifications (PTM) of
proteins, as present in all kingdoms of life. It consists in the covalent attachment of glycans
onto amino acid side chains, this reaction being catalyzed by an enzyme. In eukaryotic cells,
glycosylation has significant effects on protein folding, conformation, distribution, stability, and
activity. Particularly, the sugar chains of glycoproteins are essential for maintaining the order
of intercellular interactions among all differentiated cells in multicellular organisms. Therefore,
alterations in the sugar chains may range from being essentially undetectable to a complete
loss in particular functions (Varki, 1993). Indeed, dysfunction of protein glycosylation may lead
to development of diseases like cancer and pathogenesis of infectious diseases (Moran et al.,
2011). In the innate immune system, which is the major actor for protection against microbial
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pathogens, several host glycoproteins have been shown to
function as pattern recognition receptors (PRRs), involved in
pathogen binding (Di Gioia and Zanoni, 2015). Cell-surface
glycoproteins facing the extracellular environment are ideally
located to facilitate this host–pathogen interaction. The receptors
of the innate immune response i.e., Toll-like receptors (TLRs)
and nucleotide oligomerization domain (NOD-like) receptors
(NLRs) are glycoproteins. In the adaptative immune response,
the major components, which include class I and class II major
histocompatibility complex proteins, chemokine and cytokine
receptors, and essentially all cytokines and chemokines are
glycosylated (Opdenakker et al., 2016).
Bacterial pathogens have also evolved dedicated glycosylation
machineries. When compared to higher organisms, bacteria
are capable of producing an extraordinary amount of unique
and diverse glycans, which are principally attached to the
cell surface, and secreted molecules. Bacteria are able to
use these glycoconjugates as a range of unique and specific
ligands, which specifically interact with the host (Tytgat
and de Vos, 2016). Bacteria are covered with various types
of carbohydrate moieties. These surface-exposed bacterial
structures are often called pathogen-associated molecular
patterns (or PAMPS).
Oligosaccharides may either mediate “specific recognition”
events or provide “modulation” of biological processes. For
example, they may allow interaction of bacterial proteins with
host-derived proteins or they may modulate bacteria- and/or
host-related events (Bastos et al., 2017). All these events may
be essential for bacterial colonization, its survival and the
subsequent infection. Therefore, host immunization may be
dependent on these PTM, whether mediated by the pathogen or
by the host.
Francisella tularensis is a Gram-negative bacterium causing
the zoonotic disease tularemia in a number of mammalian
species, including humans (Sjöstedt, 2011). F. tularensis invades,
survives and replicates inside a variety of cell types, including
phagocytic and non-phagocytic cells of various species (Meibom
and Charbit, 2010), as well as arthropod-derived cells (Santic
et al., 2010). “In vivo,” F. tularensis preferentially enters host
macrophages (Clemens et al., 2005), rapidly escapes to the
cytosol where it actively multiplies (Case et al., 2014). While
the cytoplasm was initially considered as a safe nutrient-replete
haven (Ray et al., 2009), it is now clearly established that the
host cytosol may be a harsh environment by depriving nutrients
against invading bacteria (Abu Kwaik and Bumann, 2013; Zhang
and Rubin, 2013). Conversely, invading intracellular pathogens
may also “steal” nutrients of the host cell that, in turn, needs to
adapt its metabolism to control its cytosolic content (Barel et al.,
2015). Indeed, upon addition of gluconeogenic substrates, such as
oaxaloacetate and pyruvate, to the cell culture medium increased
intracellular multiplication of F. tularensis LVS was observed,
suggesting that these nutrients served as sources of glucose to feed
multiplying bacteria.
We will herein summarize what is known about the
glycosylation-deglycosylation processes occurring during
Francisella infection, as observed from either the host or the
pathogen.
HOST POINT OF VIEW
Francisella infection modifies numerous “glyco-genes” involved
in glycosylation pathways in human macrophages. Indeed, using
a glycan processing gene microarray (Chacko et al., 2011), we
observed significant changes in the level of glycosyltransferase
and glycosidase gene expression profiles in human THP-
1 monocytes, infected for 24 h with F. tularensis LVS
(Barel et al., 2016). Expression of eight genes, encoding four
glycosyltransferases and four glycosidases, was down-regulated
upon infection. These four glycosidase belonged to the EDEM
family, which is involved in ER-associated degradation (ERAD).
The expression of six genes was up-regulated upon infection,
corresponding to five glycosyltransferases and one glycosidase.
The up-regulated glycosyltransferases were involved either in
N-glycosylation or in O-glycosylation of glycoproteins. The
glycosidase gene whose expression was up-regulated, encoded
the glycosidase HEXA, which is involved in the Hexosamine
Biosynthetic Pathway (HBP) (Vaidyanathan et al., 2014).
Glycosylation occurred as soon as 1 h after entry of the
bacteria into the cells. Only three proteins were found and
characterized as carrying potential N-glycosylation residues,
while nine proteins contained potentialO-glycosylation residues.
Among them, we characterized BiP/GRP78/HSPA5 protein, a
member of the HSP70 heat shock protein family. BiP expression
was increased both at transcription and translation level, by
F. tularensis LVS infection immediately after binding to the
cells. BiP glycosylation was also induced at early stage of
infection. BiP being a key regulator of the UPR (Ni et al.,
2009; Pfaffenbach and Lee, 2011), we hypothesized that the
glycosylation-deglycosylation processes could be modified by
Francisella. This could result in direct triggering of the UPR
(including BiP) in infected cells with a decrease of the load
of newly synthesized “abnormal” proteins. In addition, among
the nine proteins containing potential O-glycosylation residues
and being glycosylated by Francisella infection, we also found
PRKCSH, the beta-subunit of glucosidase 2. This enzyme is
acting upstream BiP, in the calnexin pathway, which is also
involved in correcting misfolded proteins (Hetz et al., 2011).
Infection of human monocytes by F. tularensis LVS also
triggered the deglycosylation of the glycosylated amino acid
transporter SLC1A5 and other glycoproteins (Barel et al., 2012).
Deglycosylation induced by F. tularensis LVS was maximum at
24 h when intracellular multiplication occurred and depended
on the capacity of the bacteria to escape from the phagosomes
(Barel et al., 2012). It was not an inhibition of glycosylation since
tunicamycine had no inhibiting effect on this deglycosylation.
The enzymes involved in these glycosylation-deglycosylation
mechanisms are still not characterized.
We tried to summarize the cascade of events triggered upon
infection of macrophages by Francisella in the hypothetical
model depicted in Figure 1. The transporter SLC1A5 was chosen
as a prototypic glycosylatedmembrane protein. After its synthesis
and translocation into the ER, the protein is transported to the
Golgi where it is first glycosylated À and, from there, addressed
to the membrane via secretory vesicles. In the plasma membrane,
SLC1A5 is present only as a glycosylated protein Á (Console
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FIGURE 1 | SLC1A5 is glycosylated after passage into the Golgi ¬ and is exported to the membrane ­. Its endocytosis into the cytoplasm renders it
available to glucosidases Â, e.g., HEXA, whose transcription level is increased upon Francisella infection. The deglycosylated form of SLC1A5 has been indeed
localized only in the cytoplasm. In turn, these deglycosylated (and possibly misfolded) proteins could trigger the increase of BiP expression and its glycosylation Ã.
et al., 2015). Upon re-entry into the cytoplasm via endocytosis,
glycosylated SLC1A5 becomes available to glucosidasesÂ such as
HEXA (whose expression is induced upon Francisella infection).
The deglycosylated form of SLC1A5 has been indeed localized
only in the cytoplasm (Console et al., 2015). This deglycosylated
form of the protein (possibly misfolded) could trigger increase of
BiP expression and its glycosylation Ã.
It is tempting to suggest that the intracellular survival of
Francisella would be favored both by the control exerted on
the UPR response of the host and by the availability of free
oligosaccharides resulting from deglycosylation processes, that
could serve as nutrients.
PATHOGEN POINT OF VIEW
A large number of bacterial proteins have been found to
be glycosylated (Tan et al., 2015). They show a surprising
degree of diversity, both within and between bacterial species.
Protein glycosylation can be classified according to the glycosidic
linkage. Attachment to the amide nitrogen of asparagine
(Asn) is known as N-glycosylation, with that of serine or
threonine (Ser/Thr) to the hydroxyl oxygen being known as O-
glycosylation. N- and O-linked glycosylation may occur either
through the action of an oligosaccharyltransferase (OST) or
via the action of glycosyltransferases (GTs). OSTs substrates
are lipid-linked oligosaccharides while the GTs substrates are
usually nucleotide-activated sugars. It was only very recently
(Dankova et al., 2016) that the glycosylation machinery of
Francisella was found to involve a variety of sugar biogenesis
enzymes, glycosyltransferases, a flippase, and a protein-targeting
oligosaccharyltransferase. As both type A and type B strains of F.
tularensis subspecies expressed anO-linked protein glycosylation
system, which utilizes core biosynthetic and assembly pathways,
O-linked protein glycosylation may be a feature common to
members of the Francisella genus (Egge-Jacobsen et al., 2011).
The initial attempts to elucidate the glycan repertoire
of Francisella and their structures had failed because of
the enzymatic and chemical release techniques used. Some
proteins were found after transcriptional profiling of mutants.
Indeed, FTT_0905 was characterized as a glycosylated Type
IV pili protein, which is transcriptionally regulated by
MglA. As MglA controls the expression of the Francisella
pathogenicity island, FTT_0905 was considered as a new
virulence factor (Brotcke et al., 2006). However, by mapping
the glycoproteome of the FSC200 strain of F. tularensis
subsp. holarctica, several candidate proteins were found that
could be target for glycosylation as DsbA (FTH_1071), an
uncharacterized protein FTH_0069, FopA, Tul4, and LemA
(Balonova et al., 2010). In contrast, the PglA protein was
identified as a targeting oligosaccharyltransferase because
it is necessary for PilA glycosylation in F. tularensis (Egge-
Jacobsen et al., 2011). Indeed, this protein undergoes multisite
O-linked glycosylation, with a pentasaccharide of the structure
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HexNac-Hex-Hex-HexNac-HexNac. PglA is highly conserved
in Francisella genus, supporting the general feature of O-
glycosylation. Then, the detailed characterization of the DsbA
glycan and the putative role of the FTT0789–FTT0800 gene
cluster in glycan biosynthesis were reported (Thomas et al.,
2011). Indeed, these authors observed that the essential
virulence factor DsbA migrated as multiple protein spots
on two-dimensional electrophoresis gels. The protein was
modified with a 1,156-Da glycan moiety in O-linkage. The
glycan is a hexasaccharide, comprised of N-acetylhexosamines,
hexoses, and an unknown monosaccharide. Loss of DsbA glycan
modification was obtained by disruption of two genes within
the FTT0789–FTT0800 putative polysaccharide locus, including
a galE homolog (FTT0791) and one gene encoding a putative
glycosyltransferase (FTT0798). As the mutants remained virulent
in the murine model of subcutaneous tularemia, it indicated that
glycosylation of DsbA does not play a major role in virulence
under these conditions (Thomas et al., 2011). When defining
the previously uncharacterized FTH_0069 protein as a novel
glycosylated lipoprotein required for virulence, Balonova et al.
(2012) also showed that the glycan structure modifying its two C-
terminal peptides was identical to that of DsbA glycoprotein, as
well as to one of themultiple glycan structures modifying the type
IV pilin PilA. They therefore suggested a common biosynthetic
pathway for the protein modification and a relationship between
synthesis of the O-antigen and the glycan in the early steps of
their biosynthetic pathways. Indeed, the pglA gene, encoding
pilin oligosaccharyl transferase PglA, was involved in both pilin
and general F. tularensis protein glycosylation.
In another study on activation of pulmonary inflammation
after F. tularensis Schu S4 exposure (Walters et al., 2013), altered
expression level of bacteria-specificmRNA transcripts was found.
Among these transcripts, a hypothetical protein FTT_0797 was
characterized which shared homology with a glycosyl transferase.
This protein is part of a gene cluster, which is thought to
encode a polysaccharide additional to the lipopolysaccharide O
antigen. Another protein, encoded by FTS_1402, was found to be
involved in glycoprotein synthesis and to also contribute in part
to LPS/capsule and/or Capsule Like Complex (CLC) production
(Dankova et al., 2016). The resulting FTS_1402mutant presented
more sensitivity to serum complement.
All these proteins are summarized in Table 1.
Concerning enzymes involved in degradation pathways,
analysis of F. tularensis genomes showed a difference in the
number of genes coding for proteins with such enzymatic activity
(Table 2). Five genes were found in LVS, while only two genes
were found in SchuS4 strain and only one gene in FSC200 strain.




While two-third of all eukaryotic proteins are estimated to
be glycosylated, the number of prokaryotic glycoproteins is
still way behind understanding. This is mainly due to the
enormous variability of their glycan structures and variations
in the underlying glycosylation processes. In 2016, Schäffer and
and Messner (2016) combined glycan structural information
with bioinformatic, genetic, biochemical and enzymatic data
for in-depth analyses of glycosylation processes in prokaryotes.
This study included the major classes of prokaryotic (i.e.,
bacterial and archaeal) glycoconjugates without any example on
Francisella. Furthermore, in a very recent publication (Bastos
et al., 2017), while F. tularensis was shown to exhibit the





Protein name Characteristics Function References
FTT_0905 Type IV pili glycosylation protein Glycosylated Type IV pilus Virulence Factor Brotcke et al., 2006
FTH_1071 Dsba DsbA Glycan Biosynthesis Virulence Factor not
affected when glycan is lost.
Thomas et al., 2011
FTH_0069 Putative Glycosylation Balonova et al., 2010
fopA FopA Putative Glycosylation Balonova et al., 2010
tul4 Tul4 Putative Glycosylation Balonova et al., 2010
lemA Lema Putative Glycosylation Balonova et al., 2010
pglA PglA Oligosaccharyltransferase Pilin and Protein
glycosylation
Egge-Jacobsen et al., 2011
FTT_0789 Ribulose-phosphate 3-epimerase Glycan Biosynthesis Thomas et al., 2011
FTT_0798 Glycosyl transferase family protein Putative glycosyltransferase Thomas et al., 2011
FTH_0069 FTT_1676 Hypothetical protein Glycosylated lipoprotein Virulence Factor Balonova et al., 2012
FTT_0797 Glycosyl transferase family protein Glycosyltransferase Involved in O antigen
glycosylation
Walters et al., 2013
FTS_1402 FTT_0793 ABC transporter Putative glycan flippase Involved in LPS and CLC
product
Dankova et al., 2016
FTT, Francisella tularensis ssp. tularensis; FTH, Francisella tularensis ssp. holartica; FTS, Francisella tularensis ssp. tularensis, FSC200 stain nomenclature.
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TABLE 2 | Genes found in KEGG, with a putative deglycosylation function.
Francisella tularensis Gene number Name Function
Subsp. tularensis SCHU S4 FTT_0928c Beta-N-acetylhexosaminidase [EC:3.2.1.52] Beta-glucosidase
FTT_0412c Pullulanase [EC:3.2.1.41] PulB; pullulonase
Subsp. holarctica LVS (Live Vaccine Strain) FTL_1282 Beta-N-acetylhexosaminidase [EC:3.2.1.52] Beta-glucosidase-related glycosidase
FTL_1052 Putative glycosidase
FTL_0482 Pullulanase [EC:3.2.1.41] Pullulonase
AW21_68 Glycosyl hydrolase family 3 N terminal domain Hypothetical protein
AW21_1415 Glycosyl hydrolase family 3 N terminal domain Hypothetical protein
subsp. holarctica FSC200 FTS_1254 Beta-N-acetylhexosaminidase [EC:3.2.1.52] Glycosyl hydrolase family protein
Subsp. novicida U112 FTN_0911 Alpha-glucosidase [EC:3.2.1.20] Glycosyl hydrolases family 31 protein
FTN_0627 chitinase [EC:3.2.1.14] Chitinase, glycosyl hydrolase family 18
FTN_0806 Beta-N-acetylhexosaminidase [EC:3.2.1.52] Glycosyl hydrolase family 3
FTN_1474 bglX Glycosyl hydrolase family 3
largest number of glycoproteins in common withM. tuberculosis
(Mtb), by sharing 16% of its glycoproteome, none of the
glycosylated proteins of Francisella, as well as none of the
enzymes involved in glycosylation pathway, have been found
to play a specific role in pathogenesis. At the opposite, in
M. tuberculosis, glycosylation of HbN, a truncated hemoglobin
protein, was demonstrated to be necessary for its maintainance
at the bacterial membrane and wall (Arya et al., 2013). Mutation
in its mannose glycan linkage disrupted the facilitation of Mtb
and M. smegmatis entry within the macrophages. These data
suggested that glycosylation processes allowed Mtb survival
within the hazardous environment of macrophages and the
establishment of long term persistent infection in the host (Dey
and Bishai, 2014).
Of note, Francisella did not belong to the list of prokaryotes
that catalyzed glycosylation of host cell proteins (Bastos
et al., 2017). In contrast, Legionella was cited as targeting
eEF1A through effect of the glucosyl transferase Lgt1,
with as result, the killing of eukaryotic cells (Belyi et al.,
2008).
CONCLUSION
While 146 examples of protein glycosylation were cited for
Francisella and only 111 for Helicobacter pylori (Bastos et al.,
2017), the importance of these PTM, observed in Francisella and
those induced in the host, is still largely unknown, notably on
the outcome of the infectious cycle. Indeed, a large correlation
between glycosylation and bacterial pathogenicity has already
been proven for various species e.g., Campylobacter jejuni,
Legionella and enteropathogenic Escherichia coli (EPEC) (Lu
et al., 2015).
Francisella infection modifies the unfolded protein response
(UPR) (Barel et al., 2016) andmanipulates autophagy (Miller and
Celli, 2016). Both processes are involved in maintaining cellular
homeostasis and helping destroy invading microorganisms.
Glycosylation and deglycosylation could be involved in
molecular mimicry of common host cell glycans therefore
helping the bacteria to avoid immune recognition. At this
stage, we have all the reasons to believe that the glycosylation-
deglycosylation processes observed in THP-1 cells were
originated from eukaryotic enzymes. However, we cannot
formerly exclude that Francisella enzymes might also be
involved. Glycans and glycan-binding receptors influence
all stages of infection, starting from initial colonization of
host epithelial surfaces to spreading in tissue and inducing
inflammation or host-cell injury, which may results in clinical
symptoms (Nizet and Esko, 2009). Therefore, knowledge of
glycosylation pathways involved during Francisella infection
remains fundamental for prevention and treatment strategies.
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